$IZEA
IZEA Worldwide, Inc.

2020 Q4 Form 10-Q Financial Statement

#000149523120000144 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $6.390M $4.208M $4.411M
YoY Change 9.61% -4.61% -23.7%
Cost Of Revenue $2.740M $1.751M $1.904M
YoY Change 1.48% -8.06% -20.57%
Gross Profit $3.650M $2.457M $2.507M
YoY Change 16.61% -1.99% -25.91%
Gross Profit Margin 57.12% 58.39% 56.83%
Selling, General & Admin $4.290M $3.230M $3.270M
YoY Change -14.54% -1.22% -23.49%
% of Gross Profit 117.53% 131.48% 130.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $410.0K $372.5K $433.1K
YoY Change -4.65% -13.99% 16.84%
% of Gross Profit 11.23% 15.16% 17.28%
Operating Expenses $4.700M $3.230M $5.608M
YoY Change -13.76% -42.39% -20.37%
Operating Profit -$1.050M -$1.146M -$1.197M
YoY Change -54.74% -4.23% -5.15%
Interest Expense -$20.00K $16.45K $27.73K
YoY Change -300.0% -40.69% -69.34%
% of Operating Profit
Other Income/Expense, Net $20.00K $13.64K $23.55K
YoY Change 0.0% -42.1% -133.02%
Pretax Income -$1.040M -$1.250M -$1.170M
YoY Change -54.59% 6.84% -12.03%
Income Tax
% Of Pretax Income
Net Earnings -$1.040M -$1.132M -$1.173M
YoY Change -54.59% -3.47% -11.99%
Net Earnings / Revenue -16.28% -26.91% -26.59%
Basic Earnings Per Share
Diluted Earnings Per Share -$21.43K -$27.31K -$36.09K
COMMON SHARES
Basic Shares Outstanding 48.46M shares 48.41M shares 34.51M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.05M $30.62M $6.810M
YoY Change 462.07% 349.63% 76.42%
Cash & Equivalents $33.05M $30.62M $6.809M
Short-Term Investments
Other Short-Term Assets $74.47K $140.3K $56.19K
YoY Change -51.34% 149.67% -33.39%
Inventory
Prepaid Expenses $226.6K $414.7K $623.0K
Receivables $5.207M $3.981M $4.498M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $38.55M $35.15M $11.99M
YoY Change 220.36% 193.31% 5.75%
LONG-TERM ASSETS
Property, Plant & Equipment $230.9K $261.0K $232.4K
YoY Change -25.46% 12.29% -24.87%
Goodwill $4.017M $4.017M $8.317M
YoY Change -51.7% -51.7% 0.0%
Intangibles $505.6K $768.9K $2.207M
YoY Change -68.63% -65.15% -36.46%
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $140.0K
YoY Change -100.0% -100.0% -6.67%
Total Long-Term Assets $6.226M $6.527M $12.74M
YoY Change -47.72% -48.79% -5.5%
TOTAL ASSETS
Total Short-Term Assets $38.55M $35.15M $11.99M
Total Long-Term Assets $6.226M $6.527M $12.74M
Total Assets $44.78M $41.68M $24.73M
YoY Change 87.01% 68.54% -0.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.311M $1.743M $1.691M
YoY Change 2.59% 3.05% -40.27%
Accrued Expenses $1.925M $1.268M $1.439M
YoY Change 39.74% -11.9% -32.98%
Deferred Revenue $6.635M $6.462M $5.440M
YoY Change 2.6% 18.77% -3.39%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.510M $1.190M
YoY Change
Total Short-Term Liabilities $12.35M $10.63M $8.782M
YoY Change 21.29% 21.03% -48.06%
LONG-TERM LIABILITIES
Long-Term Debt $500.0K $840.0K $0.00
YoY Change 900.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $500.0K $840.0K $0.00
YoY Change 900.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.35M $10.63M $8.782M
Total Long-Term Liabilities $500.0K $840.0K $0.00
Total Liabilities $12.85M $11.47M $8.780M
YoY Change 25.67% 30.67% -48.2%
SHAREHOLDERS EQUITY
Retained Earnings -$70.49M -$69.41M -$58.09M
YoY Change 17.49% 19.48% 10.86%
Common Stock $5.005K $4.833K $3.451K
YoY Change 44.49% 40.05% 185.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.93M $30.21M $15.95M
YoY Change
Total Liabilities & Shareholders Equity $44.78M $41.68M $24.73M
YoY Change 87.01% 68.54% -0.37%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$1.040M -$1.132M -$1.173M
YoY Change -54.59% -3.47% -11.99%
Depreciation, Depletion And Amortization $410.0K $372.5K $433.1K
YoY Change -4.65% -13.99% 16.84%
Cash From Operating Activities -$100.0K -$70.00K -$2.120M
YoY Change -84.13% -96.7% -2.75%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$180.0K -$160.0K
YoY Change 0.0% 12.5% -33.33%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$110.0K $40.00K
YoY Change -100.0% -375.0% 300.0%
Cash From Investing Activities -$100.0K -$290.0K -$120.0K
YoY Change 0.0% 141.67% -50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.620M 10.16M -280.0K
YoY Change -1478.95% -3728.57% -106.36%
NET CHANGE
Cash From Operating Activities -100.0K -70.00K -2.120M
Cash From Investing Activities -100.0K -290.0K -120.0K
Cash From Financing Activities 2.620M 10.16M -280.0K
Net Change In Cash 2.420M 9.800M -2.520M
YoY Change -363.04% -488.89% -227.27%
FREE CASH FLOW
Cash From Operating Activities -$100.0K -$70.00K -$2.120M
Capital Expenditures -$100.0K -$180.0K -$160.0K
Free Cash Flow $0.00 $110.0K -$1.960M
YoY Change -100.0% -105.61% 1.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001495231
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48459607 shares
dei Entity Address Address Line1
EntityAddressAddressLine1
501 N. Orlando Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 313
dei Entity Address Address Line3
EntityAddressAddressLine3
PMB 247
dei Entity Address City Or Town
EntityAddressCityOrTown
Winter Park
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48331379 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34634172 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48331379 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34634172 shares
izea Periodwhichcashreservesandfinancingsourcesareexpectedtobeavailabletocoverexpenses
Periodwhichcashreservesandfinancingsourcesareexpectedtobeavailabletocoverexpenses
P1Y
izea Contractassetsandcontractliabilitieslengthofagreementwithcustomers
Contractassetsandcontractliabilitieslengthofagreementwithcustomers
P1Y
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
izea Bad Debt Expense Percentageof Revenues
BadDebtExpensePercentageofRevenues
0.01
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2019Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
369 USD
CY2020Q3 izea Lengthofcontractwithcustomers
Lengthofcontractwithcustomers
P1Y
dei Document Type
DocumentType
10-Q
CY2020Q3 izea Lengthofcontractwithcustomers
Lengthofcontractwithcustomers
P1Y
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37703
dei Entity Registrant Name
EntityRegistrantName
IZEA WORLDWIDE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1530765
dei Entity Address Address Line1
EntityAddressAddressLine1
501 N. Orlando Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 313
dei Entity Address Address Line3
EntityAddressAddressLine3
PMB 247
dei Entity Address City Or Town
EntityAddressCityOrTown
Winter Park
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32789
dei City Area Code
CityAreaCode
407
dei Local Phone Number
LocalPhoneNumber
674-6911
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
IZEA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48459607 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30617921 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5884629 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3981132 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5596719 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
385128 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
400181 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
140291 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
153031 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
35124472 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
12034560 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
260994 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
309780 USD
CY2020Q3 us-gaap Goodwill
Goodwill
4016722 USD
CY2019Q4 us-gaap Goodwill
Goodwill
8316722 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
768879 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1611516 USD
CY2020Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1480288 USD
CY2019Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1519980 USD
CY2020Q3 us-gaap Security Deposit
SecurityDeposit
0 USD
CY2019Q4 us-gaap Security Deposit
SecurityDeposit
151803 USD
CY2020Q3 us-gaap Assets
Assets
41651355 USD
CY2019Q4 us-gaap Assets
Assets
23944361 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1333281 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2252536 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1267553 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1377556 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7028687 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6466766 USD
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1157103 USD
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
83807 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10786624 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10180665 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
65604 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
45673 USD
CY2020Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
778092 USD
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2020Q3 us-gaap Liabilities
Liabilities
11630320 USD
CY2019Q4 us-gaap Liabilities
Liabilities
10226338 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
4833 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
3464 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99610374 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
74099328 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69594172 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60384769 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
30021035 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
13718023 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41651355 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23944361 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4036120 USD
CY2019Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4411086 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11934827 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13128706 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
1701770 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
1701770 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
1904287 USD
us-gaap Cost Of Revenue
CostOfRevenue
5256536 USD
us-gaap Cost Of Revenue
CostOfRevenue
5821237 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1403037 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1518165 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4154871 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4238074 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1827267 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1752126 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6165597 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6596485 USD
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4300000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
372483 USD
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
433094 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1250859 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1317423 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
5304557 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
5607672 USD
us-gaap Costs And Expenses
CostsAndExpenses
21127863 USD
us-gaap Costs And Expenses
CostsAndExpenses
17973219 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1268437 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1196586 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9193036 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4844513 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
16448 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
27734 USD
us-gaap Interest Expense
InterestExpense
42542 USD
us-gaap Interest Expense
InterestExpense
242935 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30085 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51285 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26175 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
91447 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13637 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23551 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16367 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-151488 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1254800 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1173035 USD
us-gaap Net Income Loss
NetIncomeLoss
-9209403 USD
us-gaap Net Income Loss
NetIncomeLoss
-4996001 USD
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45772638 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32421043 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38879218 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22506929 shares
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
20980331 USD
CY2020Q3 izea Stock Issued During Period Sale Of Securityvalue
StockIssuedDuringPeriodSaleOfSecurityvalue
10378440 USD
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31250 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
222754 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
108568 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1254800 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
30021035 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
13933580 USD
CY2019Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2928375 USD
CY2019Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
37509 USD
CY2019Q3 izea Adjustments In Excess Of Cost Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsInExcessOfCostAdditionalPaidInCapitalStockIssuedIssuanceCosts
1704 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
219494 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1173035 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
15947627 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
13718023 USD
izea Stock Issued During Period Sale Of Securityvalue
StockIssuedDuringPeriodSaleOfSecurityvalue
25740293 USD
izea Stock Issued During Period Value Employee Purchase Price Plan And Stock Options Exercised
StockIssuedDuringPeriodValueEmployeePurchasePricePlanAndStockOptionsExercised
2313 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
93749 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
680786 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
356846 USD
us-gaap Net Income Loss
NetIncomeLoss
-9209403 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
30021035 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7218315 USD
izea Stock Issued During Period Sale Of Securityvalue
StockIssuedDuringPeriodSaleOfSecurityvalue
10000000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4004397 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3096 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
112504 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
772853 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
378169 USD
us-gaap Net Income Loss
NetIncomeLoss
-4996001 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1507206 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2604095 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
15947627 USD
us-gaap Net Income Loss
NetIncomeLoss
-9209403 USD
us-gaap Net Income Loss
NetIncomeLoss
-4996001 USD
us-gaap Depreciation
Depreciation
102495 USD
us-gaap Depreciation
Depreciation
99814 USD
izea Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
1148364 USD
izea Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
1217609 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4300000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
22423 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23903 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108381 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-29940 USD
us-gaap Share Based Compensation
ShareBasedCompensation
356846 USD
us-gaap Share Based Compensation
ShareBasedCompensation
498071 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
93749 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
112504 USD
izea Gainlossonsettlementofacquisitioncostspayable
Gainlossonsettlementofacquisitioncostspayable
0 USD
izea Gainlossonsettlementofacquisitioncostspayable
Gainlossonsettlementofacquisitioncostspayable
602410 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
80038 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
231879 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
151803 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
839 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-919255 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-926628 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-121665 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-489440 USD
izea Changeincontractwithcustomerliability
Changeincontractwithcustomerliability
561921 USD
izea Changeincontractwithcustomerliability
Changeincontractwithcustomerliability
482498 USD
izea Changeinrightofuseassets
Changeinrightofuseassets
-24024 USD
izea Changeinrightofuseassets
Changeinrightofuseassets
26148 USD
izea Increase Decrease Deferred Rent
IncreaseDecreaseDeferredRent
0 USD
izea Increase Decrease Deferred Rent
IncreaseDecreaseDeferredRent
-17419 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1997995 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2280532 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
17290 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
127227 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
43317 USD
izea Payments To Proceeds From Developed Software
PaymentsToProceedsFromDevelopedSoftware
266035 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
29007 USD
izea Payments To Proceeds From Developed Software
PaymentsToProceedsFromDevelopedSoftware
499363 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-254318 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-583273 USD
izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
25740293 USD
izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
10000000 USD
izea Proceeds From Employee Stock Purchase Plan And Stock Options Exercised
ProceedsFromEmployeeStockPurchasePlanAndStockOptionsExercised
2313 USD
izea Proceeds From Employee Stock Purchase Plan And Stock Options Exercised
ProceedsFromEmployeeStockPurchasePlanAndStockOptionsExercised
3096 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1526288 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1935195 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
11410 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
680786 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
772853 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26985605 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7703955 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24733292 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4840150 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5884629 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1968403 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30617921 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6808553 USD
us-gaap Interest Paid Net
InterestPaidNet
39834 USD
us-gaap Interest Paid Net
InterestPaidNet
204187 USD
izea Equipmentacquiredwithfinancingarrangement
Equipmentacquiredwithfinancingarrangement
43003 USD
izea Equipmentacquiredwithfinancingarrangement
Equipmentacquiredwithfinancingarrangement
0 USD
izea Acquisitioncostspaidthroughissuanceofcommonstock
Acquisitioncostspaidthroughissuanceofcommonstock
0 USD
izea Acquisitioncostspaidthroughissuanceofcommonstock
Acquisitioncostspaidthroughissuanceofcommonstock
4004397 USD
izea Fairvalueofcommonstockissuedforfutureservices
Fairvalueofcommonstockissuedforfutureservices
125000 USD
izea Fairvalueofcommonstockissuedforfutureservices
Fairvalueofcommonstockissuedforfutureservices
192550 USD
izea Wagereductionduetopandemicpercentage
Wagereductionduetopandemicpercentage
0.20
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69594172 USD
us-gaap Net Income Loss
NetIncomeLoss
-9209403 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30617921 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which COVID-19 impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it impacts worldwide macroeconomic conditions, the speed of the anticipated recovery, access to capital markets, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September 30, 2020 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to estimates related to revenue, the accounting for potential liabilities and accrued expenses, the assumptions utilized in valuing stock-based compensation issued for services, the realization of deferred tax assets, and assessments of impairment related to long-lived assets and intangibles. The Company’s </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the Company’s efforts, the ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the full extent to which COVID-19 will negatively impact its financial results or liquidity. However, in consideration of the effect of COVID-19 on the assumptions and estimates used in the preparation of the September 30, 2020 financial statements, the Company identified the goodwill impairment disclosed in Note 3 as a material adverse effect on its results of operations and financial position in the first quarter of fiscal 2020 that was caused by COVID-19’s effect on economic conditions.</span></div>
CY2020Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3947837 USD
CY2020Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
33295 USD
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
5106314 USD
CY2019Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
490405 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
170000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
145000 USD
izea Bad Debt Expense Percentageof Revenues
BadDebtExpensePercentageofRevenues
0.01
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of credit risk with respect to accounts receivable have been typically limited because a large number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk. However, with the Company’s addition of SaaS customers, it has increased credit exposure on certain customers who carry significant credit balances related to their marketplace spend. The Company controls credit risk through credit approvals, credit limits and monitoring procedures. The Company performs credit evaluations of its customers, but generally does not require collateral to support accounts receivable. The Company had one customer that accounted for 25% of total accounts receivable at September 30, 2020 and no customers that accounted for an aggregate of more than 10% of total accounts receivable at December 31, 2019. The Company had no customer that accounted for more than 10% of its revenue during the three months ended September 30, 2020 or 2019. The Company had no customer that accounted for more than 10% of its revenue during the nine months ended September 30, 2020 or 2019.
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 operating_units
izea Amortizationperiodofsoftwaredevelopmentcosts
Amortizationperiodofsoftwaredevelopmentcosts
P5Y
izea Leaseterm
Leaseterm
P12M
izea Leaseterm
Leaseterm
P12M
izea Invoicepaymentterms
Invoicepaymentterms
P30D
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
800575 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1178115 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
539581 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
868335 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
260994 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
309780 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5442590 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4599953 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5442590 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4599953 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
768879 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1611516 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P1Y4M
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
236490 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
532389 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
768879 USD
CY2019Q4 us-gaap Goodwill
Goodwill
8316722 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4300000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
4016722 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4300000 USD
CY2020Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2939052 USD
CY2019Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2673017 USD
CY2020Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1458764 USD
CY2019Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1153037 USD
CY2020Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1480288 USD
CY2019Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1519980 USD
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
266035 USD
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
499363 USD
CY2020Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2939052 USD
CY2020Q3 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1031266 USD
CY2019Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1202765 USD
CY2020Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
153823 USD
CY2019Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
117698 USD
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
28603 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
26837 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
53861 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
30256 USD
CY2020Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1267553 USD
CY2019Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1377556 USD
CY2020Q3 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
3200000 USD
CY2020Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
12250 USD
izea Numberofmaterialleases
Numberofmaterialleases
1 leases
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
410852 USD
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
399892 USD
CY2019Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.095
izea Operatingleaserightofuseassetamortization
Operatingleaserightofuseassetamortization
24024 USD
izea Numberoffinanceleaseobligations
Numberoffinanceleaseobligations
0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 izea Gain On Settlement Acquisition
GainOnSettlementAcquisition
752591 USD
CY2019Q1 izea Numberofindependentdirectors
Numberofindependentdirectors
6 directors
CY2020Q1 izea Numberofindependentdirectors
Numberofindependentdirectors
5 directors
CY2011Q3 izea Percentageofindividualownershipofcommonstock
Percentageofindividualownershipofcommonstock
0.10
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
369 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
265 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
371227 USD
CY2020Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
55202 USD
CY2019Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
97220 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
166955 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
277220 USD
CY2019Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3500000 USD
us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2020-12-31
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1254800 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1173035 USD
us-gaap Net Income Loss
NetIncomeLoss
-9209403 USD
us-gaap Net Income Loss
NetIncomeLoss
-4996001 USD
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45772638 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32421043 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38879218 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22506929 shares
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.03
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.24
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.22
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2822861 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1772100 shares
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6466766 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3981132 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5596719 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7028687 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2768637 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1602698 shares
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4036120 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4411086 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11934827 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13128706 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4036120 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4411086 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11934827 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13128706 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11934827 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13128706 USD
us-gaap Cost Of Revenue
CostOfRevenue
5256536 USD
us-gaap Cost Of Revenue
CostOfRevenue
5821237 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4154871 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4238074 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6165597 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6596485 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4300000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1250859 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1317423 USD
us-gaap Interest Expense
InterestExpense
42542 USD
us-gaap Interest Expense
InterestExpense
242935 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26175 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
91447 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4300000 USD
us-gaap Interest Expense
InterestExpense
42542 USD

Files In Submission

Name View Source Status
0001495231-20-000144-index-headers.html Edgar Link pending
0001495231-20-000144-index.html Edgar Link pending
0001495231-20-000144.txt Edgar Link pending
0001495231-20-000144-xbrl.zip Edgar Link pending
exhibit101directorcomp.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
izea-20200930.htm Edgar Link pending
izea-20200930.xsd Edgar Link pending
izea-20200930_cal.xml Edgar Link unprocessable
izea-20200930_def.xml Edgar Link unprocessable
izea-20200930_htm.xml Edgar Link completed
izea-20200930_lab.xml Edgar Link unprocessable
izea-20200930_pre.xml Edgar Link unprocessable
izea200930ex311.htm Edgar Link pending
izea200930ex312.htm Edgar Link pending
izea200930ex321.htm Edgar Link pending
izea200930ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending